Cepheid has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its rapid molecular diagnostic test, Xpert Xpress SARS-CoV-2. The test is designed for the qualitative detection of SARS-CoV-2 virus, which causes coronavirus (Covid-19) disease.
Portfolio News: ClinCapture, Inc. is Providing Free Electronic Data Capture (EDC) for Clinical Researchers Investigating the Treatment of COVID-19 Coronavirus
Band portfolio company ClinCapture, Inc., a leading provider for Electronic Data Capture (EDC) systems and eClinical solutions, announced that it will begin offering EDC at no cost for specific clinical trials investigating COVID-19 Coronavirus. The decision to offer free EDC for BioPharma and Diagnostic companies conducting COVID-19 clinical trials was announced after the World Health Organization issued a statement that the confirmed number of COVID-19 cases has surpassed 100,000 globally.
Portfolio News: CNote Named Emerging Impact Manager on the 2020 Impact Assets 50 List
CNote, an award-winning, first-of-its-kind financial platform that allows anyone to make money investing in causes and communities they care about, was listed as an Emerging Impact Manager on the 2020 Impact Assets 50 list of fund managers
Portfolio News: Your Fare Oversubscribes First Round Of Equity Funding, Receives $2.4M
Your Fare, an online third-party delivery management solution for restaurants, has successfully closed $2.4 million in equity funding from several marquee angel networks including Band of Angels, Houston Angel Network, Capital Factory, Sierra Angels and Texas HALO Fund. The funding will support Your Fare's growth and investment in its innovative software.
Portfolio News: Corporate relocation startup Shyft raises $15M
Shyft is announcing it has raised $15 million in Series A funding to make the moving process less painful — specifically in the situations where your employer is paying for the move.